# Editorial: Advances and methods in mesenchymal stem cells

**Authors:** Pamela L. Wenzel

PMC · DOI: 10.3389/fcell.2024.1382019 · Frontiers in Cell and Developmental Biology · 2024-02-26

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, NTF3 (neurotrophin 3) [NCBI Gene 4908] {aka HDNF, NGF-2, NGF2, NT-3, NT3}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, gp130 [NCBI Gene 4827]
- **Diseases:** loss of the skin's pigmentation (MESH:D010859), leukemia (MESH:D007938), neurological injury (MESH:D020196), autoimmune (MESH:D001327), hypoxic (MESH:D002534), central nervous system injury (MESH:D002493), hematological disease (MESH:D006402), fibrosis (MESH:D005355), muscle wasting (MESH:D009133), Vitiligo (MESH:D014820), muscle injury (MESH:D009135), scarring (MESH:D002921), hematological malignancies (MESH:D019337)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10925746/full.md

---
Source: https://tomesphere.com/paper/PMC10925746